#germanybfarm — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #germanybfarm, aggregated by home.social.
-
Silexion Files German Trial Application for SIL204
Silexion Therapeutics (NASDAQ: SLXN) submitted a Clinical Trial Application to Germany’s BfArM via…
#Germany #DE #Europe #EU #Europa #clinicaltrialapplication #GermanyBfArM #pancreaticcancer #Phase2/3 #RNAi #SIL204 #SilexionTherapeutics #SLXN
https://www.europesays.com/germany/8223/